Stanford University
Showing 3,701-3,800 of 13,039 Results
-
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Rabin Gerrah
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Rabin Gerrah is a cardiothoracic surgeon and specializes in surgical treatment of heart diseases such as ischemic, valvular, structural and congenital heart diseases. He has been trained at Harvard University and Columbia University Hospitals. Dr. Gerrah has been involved in multiple medical research projects and has patented and developed innovative surgical devices and technologies.
-
Elias Roth Gerrick
Member, Maternal & Child Health Research Institute (MCHRI)
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Neil Gesundheit
George DeForest Barnett Founders Professor of Medicine and Professor (Teaching) of Medicine (Endocrinology)
Current Research and Scholarly InterestsOur medical education research group is developing and validating the best educational practices to train competent, compassionate, and ethical physicians and physician-scientists. We are studying the use of standardized patients and other modalities to improve clinical skill training and reasoning. We are interested in applying the rigor of clinical investigation to education research.
My areas of clinical interest in endocrinology include disorders of the pituitary, thyroid, and gonad. -
Olivier Gevaert
Associate Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsMy lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.
-
Ishita Ghai
Postdoctoral Scholar, General Internal Medicine
BioIshita Ghai is a health policy researcher that applies causal inference methods to understand how health behaviors are shaped through individual and group factors in low-resource settings. She mainly studies these empirical questions in the context of randomized controlled trials, or through evaluations leveraging exogenous shocks using quasi-experimental techniques. She has managed several pilot and large randomized controlled trials across sub-Saharan Africa studying the short and long-term effects of health interventions on health outcomes for women, children, and people living with HIV/AIDS. At Stanford, she will advance work on medicine policy specifically focused on the effects of the shingles vaccine on dementia risk among older populations.
She completed her doctoral studies in policy analysis (economics concentration) at the RAND School of Public Policy, and holds an MBA from the University of California, Davis, an Ed.M. in international education policy from Harvard University, and a B.Tech in bioinformatics from VIT University. -
Marc Ghanem
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMarc's research focuses on leveraging deep learning to identify clinically relevant patterns within large medical datasets, aiming to deliver personalized and predictive healthcare solutions. Current projects include building comprehensive perioperative foundation model, optimizing neonatal total parenteral nutrition (TPN), analyzing anesthesiology research trends, and identifying differential responders and their characteristics in clinical trials.
-
Pejman Ghanouni, MD, PhD
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology
BioDr. Ghanouni is a board-certified, fellowship-trained diagnostic radiologist with Stanford Health Care Radiology. He is an associate professor in the Department of Radiology, Division of Body MRI at Stanford University School of Medicine, and by courtesy, of Urology, of Neurosurgery, and of Obstetrics and Gynecology.
Dr. Ghanouni is the director of the Stanford Health Care Minimally Invasive MR Interventional Center (MIMRIC) and the Focused Ultrasound Center of Excellence. He is also chief of the Division of Body MRI at Stanford University School of Medicine.
Dr. Ghanouni is recognized around the world for his extensive expertise in using advanced imaging to diagnose, manage, and treat a wide range of conditions and disorders. As a renowned leader in diagnostic and MRI-guided interventional radiology, Dr. Ghanouni creates a customized care plan for each of his patients.
Dr. Ghanouni’s research interests include the latest advances in MR-guided focused ultrasound techniques to treat essential tremor, Parkinson’s disease, prostate cancer, bone tumors, desmoid tumors, and uterine fibroids. An experienced physician-scientist, Dr. Ghanouni has collaboratively led clinical trials and research initiatives that explore treatments for epilepsy, pancreatic cancer, and several types of tumors. Through these clinical trials, Dr. Ghanouni has helped secure FDA approval for many MR-guided focused ultrasound treatments.
His articles have been published in dozens of peer-reviewed medical journals, including Lancet Oncology, Neurology, Investigative Radiology, European Radiology, Journal of Magnetic Resonance Imaging, Journal of Neurosurgery, New England Journal of Medicine, and Radiology. Dr. Ghanouni has been invited to speak at conferences and symposiums all over the nation and the world, including in Rome, Italy; Tel Aviv, Israel; and Riyadh, Saudi Arabia. He is widely regarded for his groundbreaking research as well as his clinical expertise.
Dr. Ghanouni is a member of several professional organizations, including the International Society for Magnetic Resonance in Medicine, the International Society for Therapeutic Ultrasound, and the European Focused Ultrasound Society.
MR-guided focused ultrasound treatment: https://www.youtube.com/watch?v=3Bwq2YxD9eU -
Laleh Gharahbaghian, MD
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsEmergency Ultrasound,
Resident Education,
Interesting Cases,
Visual Diagnosis -
Zahra Ghazi-Askar
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsBioDr. Ghazi-Askar is Assistant Professor of Emergency Medicine and, by courtesy, of Pediatrics and serves as the Director of Pediatric Ultrasound Education in the Department of Emergency Medicine . As an academic clinical educator in with expertise in pediatric and adult point-of-care ultrasound, Dr. Ghazi-Askar's clinical focus is on children and young adults who seek care in the pediatric emergency department. She is specialty-board certified in pediatric emergency medicine.
At a national level, Dr. Ghazi-Askar is the Chair of Point-of-Care Ultrasound subcommittee for the Association of Pediatric Program Directors (APPD), where she is leading the development of an educational curriculum for pediatric residency point-of-care ultrasound.
Dr. Ghazi-Askar also has expertise in the field of Tele-ultrasound, where she is able to teach point-of-care ultrasound virtually where clinical expertise may otherwise not be available. Here she is able to provide education and health equity when it is most needed. -
Zaniar Ghazizadeh
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ghazizadeh is a Cardiac Electrophysiologist at Stanford. He completed his Internal Medicine residency at Yale before moving to Stanford to pursue fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology.
Dr. Ghazizadeh's clinical interests focus on the management of complex cardiac arrhythmias. His research centers on developing computational and wet-lab platforms to study cardiac electrophysiology and the mechanisms underlying cardiac arrhythmias.
His work integrates a broad range of systems, including human biobanks, genetically engineered human and animal models, and nontraditional model organisms, to uncover the molecular and physiological basis of cardiac arrhythmias. His research has been supported by NIH, AHA, and several Stanford University funding programs. As a clinician-scientist, his long-term goal is to translate these discoveries into improved risk stratification tools and novel therapeutic strategies to prevent and treat cardiac arrhythmias. -
Talayeh Ghezelayagh
Instructor, Obstetrics & Gynecology - Gynecologic Oncology
BioTalayeh Ghezelayagh, M.D., M.P.H, is an Instructor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology at Stanford University School of Medicine. She received her medical degree from the University of San Francisco, CA School of Medicine and earned a master’s in public health at the Harvard T.H. Chan School of Public Health. She then completed residency in obstetrics and gynecology and a fellowship in gynecologic oncology at the University of Washington.
Dr. Ghezelayagh’s research focuses on improving cancer risk predictions and health outcomes in patients at increased familial or genetic risk of gynecologic cancers. She is a clinically active gynecologic oncologist but spends much of her clinical work counseling and treating patients at higher risk for developing gynecologic cancers. -
Amato J. Giaccia
Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsDuring the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.
-
Luciana Giambarberi, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Giambarberi is a double-board-certified physician who completed her general psychiatry residency training at Wake Forest University School of Medicine and her Behavioral Neurology and Neuropsychiatry (BNNP) fellowship training at Stanford University School of Medicine. Her past experience includes leading, creating, expanding, and providing neuropsychiatry education and care to communities across the southeast region.
As a clinical associate professor in the Department of Psychiatry at Stanford, Dr. Giambarberi supervises trainees in the Neuropsychiatry Section and the Individual Psychotherapy Clinic. Dr. Giambarberi's administrative duties include serving as director of the Movement Disorders Clinic and director of BNNP didactics, as well as overseeing neurology core rotations and elective rotations within the neuropsychiatry section.
Dr. Giambarberi has extensive clinical experience with a diverse neuropsychiatric patient population, and her research is primarily grounded in education. She is also an active member and contributor to national and international neuropsychiatric organizations.
***For clinic appointment requests and referrals, please call 650-498-9111. -
Sachi Gianchandani
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population Health
Staff, Neurology ResearchBioSachi Gianchandani, MD, is a palliative care physician and neurologist at the VA Palo Alto Health Care System, where she provides comprehensive care for veterans. Her current roles include providing neuropalliative care in the ALS Interdisciplinary Clinic and attending on the inpatient palliative care, hospice, and neurology services.
She completed her medical school at Oakland University William Beaumont School of Medicine, neurology residency at The Ohio State University, and palliative care fellowship at Stanford Health Care. -
Karleen Giannitrapani
Assistant Professor of Medicine (Primary Care and Population Health)
BioIn contrast to bounded teams with static membership, dynamic teaming reflects the common challenge of interdisciplinary healthcare teams with changing rosters. Such dynamic collaboration is critical to addressing multi-faceted problems and individualizing care. At present, off the shelf interventions to improve the way healthcare teams work - often assume static and bounded teams. Dr Giannitrapani intends to leverage design approaches to build a new kind of healthcare “teaming intervention,” which respects the nature of their constantly changing membership and more closely aligns with how healthcare teams actually collaborate. Her expertise includes organizational behavior, building interdisciplinary teams, implementation science, mixed methods-research, quality improvement, pain and palliative care research, and global health.
In addition to the Assistant Professor role in Division of Primary Care and Population Health at Stanford University School of Medicine she serves as the quality lead for the section of Palliative Medicine. She is also a Core Investigator at the Center for Innovation to Implementation (Ci2i) in the VA Palo Alto Health Care System and serves as PI or co-investigator on multiple ongoing studies representing over 25 million dollars of competitive government grant funding. She is also a Director of the VA Quality Improvement Resource Center (QuIRC) for Palliative Care, supporting Geriatrics and Extended Care programs for 170 Veterans Affairs facilities nationally. In QuIRC she leads a portfolio of projects on improving the processes that interdisciplinary teams can leverage to improve pain and symptom management among high-risk patients; a specific focus of their work is to bridge the gap of poor palliative care integration in the perioperative period.
Dr Giannitrapani has given hundreds of presentations and have over 70 peer reviewed publications in high quality medical and health services delivery journals such as Medical Care, JAMA Surgery, the Journal of General Internal Medicine, the Journal of Pain and Symptom Management and Pain Medicine. She has received a 5-year VA Career Development Award on building better teams across disciplines and was an American Academy of Hospice and Palliative Medicine Research Scholar for related work. -
William Giardino
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsWe aim to decipher the neural mechanisms underlying psychiatric conditions of stress, addiction, and sleep/circadian dysregulation. Our work uses combinatorial technologies for precisely mapping, monitoring, and manipulating neural circuits that regulate emotional states. We are especially focused on the behavioral functions of neuropeptide molecules acting throughout the circuitry of the extended amygdala- particularly in a brain region called the bed nucleus of the stria terminalis (BNST).
-
Wil Gibb, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioCritical care physician with a background in emergency medicine
-
Iris C. Gibbs, MD, FACR, FASTRO
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.
-
Erin Gibson
Assistant Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsGlia make up more than half of the cells in the human brain, but we are just beginning to understand the complex and multifactorial role glia play in health and disease. Glia are decidedly dynamic in form and function. Understanding the mechanisms underlying this dynamic nature of glia is imperative to developing novel therapeutic strategies for diseases of the nervous system that involve aberrant gliogenesis, especially related to changes in myelination.
-
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
BioDr. Ruth Gibson, PhD, is a scholar at Stanford University. She holds appointments at the Center for Innovation and Global Health (CIGH) and the Center for International Security and Cooperation (CISAC). Dr. Gibson’s research focuses on war, blockades, and sanctions and their impacts on maternal and child health. Her expertise is in geopolitically complex regions of the world, crises, and what all of this means for human health.
Dr. Gibson’s research is published in internationally renowned outlets such as The Lancet and The Lancet Global Health. She publishes research on issues such as foreign aid withdrawal and impacts on mothers and children, humanitarian catastrophe in Gaza, and sanctions against Iran. Her insights have been highlighted by The New York Times, The New Yorker, and TIME. Dr. Gibson responds quickly to producers, journalists, and media outlets seeking expert analysis of critical issues in war, peace, and human lives.
She is currently co-leading a Lancet Series on Global Health and Foreign Engagement with Professor Gary Darmstadt. She leads worldwide international panels on critical issues in global health – geopolitical crisis and their impacts on health – through the Consortium of Universities for Global Health (CUGH) and Stanford’s CIGH. Dr. Gibson collaborates with the United Nations High Commission for Human Rights to develop a universal monitoring system to assess the impact of sanctions on human rights. Her research has been cited in UN General Assembly meetings. She also worked on war crimes investigations with the Yale Humanitarian Research Lab and on the International Criminal Court's prosecution of war crimes.
Dr. Gibson spent a decade working internationally, engaging in humanitarian and global health initiatives across eight countries on five continents – including conflict zones. Dr. Gibson is fluent in English and proficient in Mandarin Chinese (如詩 吉布森), French, and Spanish. She holds a postdoctoral fellowship from Stanford University, a PhD from the University of British Columbia, an Honors Bachelor of Science, and a Master of Science from the University of Toronto.
Dr. Gibson can be reached at rmgibson@stanford.edu
https://drruthgibson.com/ -
Rona Giffard
Professor of Anesthesiology, Perioperative and Pain Medicine, Emerita
Current Research and Scholarly InterestsAstrocytes, microglia and neurons interact, and have unique vulnerabilities to injury based on their patterns of gene expression and their functional roles. We focus on the cellular and molecular basis of brain cell injury in stroke. We study the effects of altering miRNA expression, altering levels of heat shock and cell death regulatory proteins. Our goal is to improve outcome by improving mitochondrial function and brain cell survival, and reducing oxidative stress and inflammation.
-
Alex Gileles-Hillel, MD
Visiting Scholar, Pediatrics - Pulmonary Medicine
BioAlex Gileles-Hillel, MD, ATSF, is a pediatric pulmonologist and sleep medicine physician at Hadassah Medical Center and Associate Professor of Pediatrics at the Hebrew University of Jerusalem. He directs the Neonatal Pulmonology Service at Hadassah and is a Visiting Scholar at Stanford University for 2026–27. His clinical interests include pediatric sleep-disordered breathing, chronic lung disease of prematurity, asthma, cystic fibrosis, primary ciliary dyskinesia, and complex respiratory disorders in infants and children.
Dr. Gileles-Hillel completed his medical training, pediatric residency, and pediatric pulmonology fellowship at the Hebrew University–Hadassah Medical Center. He then completed advanced fellowship training in sleep medicine at the University of Chicago under David Gozal, followed by postdoctoral training in vascular biology at the Hebrew University. He is the founder and director of the Gileles Lab, where his group investigates the mechanisms and consequences of obstructive sleep apnea and intermittent hypoxia, including cardiometabolic dysfunction, vascular injury, and cancer progression. The lab also develops human-derived airway organoid models to study asthma, cystic fibrosis, and primary ciliary dyskinesia, with the goal of translating mechanistic insights into improved care for children with respiratory disease. -
Rachel Gilgoff
Adjunct Clinical Associate Professor, Pediatrics - Allergy and Clinical Immunology
BioAs a board-certified general pediatrician, child abuse pediatrician, and integrative medicine specialist, Dr. Gilgoff brings a multidisciplinary, whole-family approach to ACEs, toxic stress, healing, and well-being. She is currently an advisor with the California Aces Aware Initiative, UCLA-UCSF ACEs Aware Family Resilience Network (UCAAN), and the Center for Youth Wellness, a program of Safe and Sound, as well as an Adjunct Clinical Associate Professor at Stanford University School of Medicine. She is the co-founder of the National Committee on Asthma and Toxic Stress and co-PI on “Systems-based, Multidisciplinary Assessment of Adversity and Toxic Stress for Individualized Care (The SYSTEMAATIC Project),” an ACEs and Precision Medicine research project through the California Initiative to Advance Precision Medicine (CIAPM). She co-created the “Stress Busters: Clinical Strategies for Preventing and Mitigating Toxic Stress,” a free, on-line course to help clinicians develop their clinical response to childhood adversity and toxic stress. In tandem, she led the development of the ACEs Aware Stress Busters Resource Webpage, sharing tools and resources to prevent and heal toxic stress for all of us. Dr. Gilgoff is dedicated to conducting translational research and promoting patient-centered, individualized, multidisciplinary clinical care to address health issues resulting from child abuse and toxic stress.
Board Certification:
American Board of Physician Specialties, Integrative Medicine (2022)
American Board of Pediatrics, Child Abuse Pediatrics (2011)
American Board of Pediatrics, General Pediatrics (2004)
Professional Education
Fellowship:
Integrative Psychiatry Institute, Integrative Psychiatry (2023)
Andrew Weil Center for Integrative Medicine (2022)
Stanford University Medical Center, Pediatric Integrative Medicine (2021)
UCSF Benioff Children’s Hospital Oakland and UC Davis, Child Abuse Pediatrics (2007)
Residency:
UCSF Benioff Children’s Hospital and Research Center at Oakland (2004)
Medical Education:
Keck School of Medicine, USC (2001)
Selected Publications
Gilgoff R, Marshall J, Kotz K, Ismail S, Harsamizadeh Tehrani S,…; ACEs Aware Patient Advisors; ACEs Aware Community Partner Council. (2025) “Stress Busters Toolkit for Community Based Organizations: Strategies to help clients prevent and heal from toxic stress.” California ACEs Aware Initiative, Office of the California Surgeon General, and the California Department of Health Care Services. https://www.acesaware.org/managestress/cbotoolkit/
Gilgoff, R., Mengelkoch, S,, Elbers, J., Kotz, K., Radin, A., Pasumarthi, I., Murthy, R., Sindher, S., Burke Harris, N., Slavich, G.E. (2024) The Stress Phenotyping Framework: A Multidisciplinary Biobehavioral Approach for Assessing and Therapeutically Targeting Maladaptive Stress Physiology. Stress. 27 (1).
Gilgoff R, Schwartz T, Owen M, Bhushan D, Burke Harris N. (2023) Opportunities to Treat Toxic Stress. Pediatrics. Jan 1;151(1):e2021055591.
Jeung, J., Hessler Jones, D., Frame, L., Gilgoff, R., Long, D., Thakur, N., Koita, K., Bucci, M., Burke Harris, N. (2022) A Caregiver-Child Intervention for Mitigating Toxic Stress (“The Resiliency Clinic”): A Pilot Study. Matern Child Health J.
Bhushan D, Kotz K, McCall J, Wirtz S, Gilgoff R, Dube SR, Powers C, Olson-Morgan J, Galeste M, Patterson K, Harris L, Mills A, Bethell C, Burke Harris N. (2020) Office of the California Surgeon General. Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health. Office of the California Surgeon General.
Gilgoff R, Singh L, Koita K, Gentile B, Marques SS. (2020) Adverse Childhood Experiences, Outcomes, and Interventions. Pediatr Clin North Am. Apr;67(2):259-273. -
Harcharan Gill
Kathryn Simmons Stamey Professor, Emeritus
Current Research and Scholarly InterestsBenign Prostatic Hyperplasia- Evaluation and development of new minimally invasive techniques
Endourology: developing, designing and evaluating new instruments
Bladder cancer: outcomes of treatment
BPH: cryotherapy and HIFU -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.
-
Michelle Gimenez
Social Science Research Professional 2, Emergency Medicine
Current Role at StanfordSocial Science Researcher
School of Medicine
Emergency Department -
Christophe Gimmler, MD, MFT
Casual - Non-Exempt, Multispecialty Anesthesiology
BioChristophe Gimmler, MD, MFT, Assistant Clinical Professor of Medicine (Affiliated) at Stanford School of Medicine;
Staff Physician, Medical Service, VA Palo Alto Health Care System;
Licensed Marriage and Family Therapist.
Associated Psychology Faculty, Palo Alto University
Clinical Monitor, Carhart-Harris Lab; Weill Institute for Neurosciences, UCSF
Study Physician, Open Mind Collective
_____________________________________________________________________________________________
After establishing and building the hospitalist and consult/liaison medicine service at the VA, Christophe now practices and teaches medical students and house staff in the primary care clinics there. He concurrently practices as a community psychotherapist and specializes in medical professionals. His central interest is the intersection of medicine and psychotherapy and, in particular, the application of psychological frameworks and skills to the practice of medicine, in addition to resiliency and burnout prevention. He developed the Medical Student Resiliency Skills Training program (MedReST) for the Stanford School of Medicine as well as the Resiliency Curriculum Series for the internal medicine residency program. He received as undergraduate degree in biology and psychology and an MD from the University of Virginia, completed his internal medicine residency at Stanford.
Christophe received a Master’s in Counseling Psychology from Sofia University. He has a private practice psychotherapy practice in Los Altos seeing adults and couples specializing in health care professionals (www.openpaththerapy.one). After completing a certificate in psychedelic-assisted psychotherapy at the Berkeley Center for the Science of Psychedelics, Christophe works as a Clinical Monitor at the Carhart-Harris Lab at UCSF and the Stanford Anesthesia Dream Project with the Heifets Lab, as well as a study physician at Open Mind Collective in San Francsico.
Publications:
Foster Well-being Throughout the Career Trajectory: A Developmental Model of Physician Resilience Training:
Mayo Clinic Proceedings
Cordova MJ, Gimmler CE, Osterberg LG
2020; 95 (12):
Developing institutional infrastructure for physician wellness: qualitative Insights from VA physicians.
BMC Health Services Research
Schwartz, R., Shanafelt, T. D., Gimmler, C., Osterberg, L.
2020; 20 (1): 7
Career-Long Skills for Personal and Professional Wellness: A Staged Developmental Model of Veterinarian Resilience Training.
J Vet Med Education
Cordova MJ, Gimmler C, Dibbern A, Duesterdieck-Zellmer KF.
2025 Apr 16 -
Lisa Giocomo
Professor of Neurobiology
Current Research and Scholarly InterestsMy laboratory studies the cellular and molecular mechanisms underlying the organization of cortical circuits important for spatial navigation and memory. We are particularly focused on medial entorhinal cortex, where many neurons fire in spatially specific patterns and thus offer a measurable output for molecular manipulations. We combine electrophysiology, genetic approaches and behavioral paradigms to unravel the mechanisms and behavioral relevance of non-sensory cortical organization. Our first line of research is focused on determining the cellular and molecular components crucial to the neural representation of external space by functionally defined cell types in entorhinal cortex (grid, border and head direction cells). We plan to use specific targeting of ion channels, combined with in vivo tetrode recordings, to determine how channel dynamics influence the neural representation of space in the behaving animal. A second, parallel line of research, utilizes a combination of in vivo and in vitro methods to further parse out ionic expression patterns in entorhinal cortices and determine how gradients in ion channels develop. Ultimately, our work aims to understand the ontogenesis and relevance of medial entorhinal cortical topography in spatial memory and navigation.
-
Nicholas Giori MD, PhD
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsOsteoarthritis
Medical Device Development -
Skyler Giron
Affiliate, Neurosurgery
BioCIRM Bridges Intern in the Llorente Lab, Stanford University Department of Neurosurgery
-
Anna Girsen
Dir Fin and Adm (SoM) 2, Obstetrics & Gynecology
Current Role at StanfordAs Director of Finance and Administration for Stanford’s Department of Obstetrics & Gynecology, I lead strategic, financial, and operational functions supporting clinical care, research, and education. I oversee a $60M portfolio spanning hospital partnerships, research administration, and faculty affairs—advancing innovation, equity, and precision health across Stanford Medicine.
-
Dr Michael Gisondi
Professor of Emergency Medicine (Adult Clinical/Academic)
BioDr. Michael A. Gisondi is Professor of Emergency Medicine and Assistant Dean for Academic Advising at Stanford School of Medicine. He is a medical education researcher and the Principal of The Precision Education and Assessment Research Lab (The PEARL). Dr. Gisondi a Distinguished Member of the Stanford Medicine Teaching and Mentoring Academy and the recipient of numerous prestigious teaching awards, including the National Faculty Teaching Award of the American College of Emergency Physicians and the Hal Jayne Excellence in Education Award of the Society for Academic Emergency Medicine. Loyola University Chicago Stritch School of Medicine recognized him as Alumnus of the Year in 2014.
-
Aaron D. Gitler
Stanford Medicine Basic Science Professor
Current Research and Scholarly InterestsWe investigate the mechanisms of human neurodegenerative diseases, including Alzheimer disease, Parkinson disease, and ALS. We don't limit ourselves to one model system or experimental approach. We start with yeast, perform genetic and chemical screens, and then move to other model systems (e.g. mammalian tissue culture, mouse, fly) and even work with human patient samples (tissue sections, patient-derived cells, including iPS cells) and next generation sequencing approaches.
-
Linda Giudice
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsOur research is in reproductive endocrinology and reproductive genomics. It focuses on human endometrial biology as it relates to basic biological mechanisms underlying steroid hormone action in this tissue, normal and abnormal placenta-decidua interactions, mechanisms underlying placentation and abnormal fetal growth, endometrial stem cells, and functional genomics for diagnostics and therapeutics of endometrial disorders. We also study mechanisms underlying ovarian follicle steroidogenesis.
-
Diona Gjermeni
Affiliate, Med/Stanford Center for Clinical Research
BioDiona Gjermeni is a clinical physician with dual specialization in Internal Medicine and Cardiology (board certified in Germany). With a strong focus on clinical research and trials, her previous work primarily revolves around antithrombotic therapy, atrial fibrillation and precision medicine. Currently she is actively engaged as Research Fellow at the Stanford Center for Clinical Research (SCCR), where she is involved in a variety of cardiovascular clinical trials across multiple phases, with particular emphasis on digital health, heart failure, and cardiac arrhythmias. Her research aims to improve patient outcomes through innovative therapies and precision medicine.
-
Bertil Glader
Stanford Medicine Professor of Pediatric Hematology/Oncology, Emeritus
Current Research and Scholarly InterestsHematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.
-
Nicole Gladish
Research Fellow, Epidemiology and Population Health
BioDr. Nicole Gladish is a Research Fellow in the Department of Epidemiology and Population Health at Stanford University. Her work integrates genetic, epigenetic, and population-level data to understand how biological and environmental factors interact to shape health disparities and influence trajectories of healthy aging. In addition to exploring molecular mechanisms, she conducts applied research on health policy interventions developing and refining tools like deprivation indices to inform equitable decision-making at the systems level.
Dr. Gladish earned her Ph.D. in Medical Genetics from the University of British Columbia (UBC), where her thesis focused on how early-life adversity, such as low socioeconomic status and abuse, affects DNA methylation patterns. This work aimed to elucidate the biological mechanisms that predispose individuals to chronic diseases such as cardiovascular disease, diabetes, and cancer.
At Stanford, she continues to investigate the interplay between social determinants and biological risk, with a growing emphasis on translational research. Her development of improved social deprivation indices supports more accurate identification of disadvantaged communities, informing public health funding, service allocation, and structural interventions across the U.S.
Dr. Gladish's work bridges molecular epidemiology and public policy, aiming to ensure that scientific insights translate into measurable improvements in population health. -
Alan M Glaseroff
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.
Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.
Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB -
Greg Glasscock
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsNeonatal Endocrinology
-
Jeffrey S. Glenn, M.D., Ph.D.
Joseph D. Grant Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.
-
Natasha Abadilla Glenn
Fellow in Adult Neurology
Current Research and Scholarly Interestsglobal health, public health, health disparities, advocacy, pediatric neurology
-
Giancarlo Glick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
-
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
-
Gary Glover
Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Psychology and of Electrical Engineering
Current Research and Scholarly InterestsMy present research is devoted to the advancement of functional magnetic resonance imaging sciences for applications in basic understanding of the brain in health and disease. We collaborate closely with departmental clinicians and with others in the school of medicine, humanities, and the engineering sciences.
-
Anna L Gloyn
Professor of Pediatrics (Endocrinology) and of Genetics
Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.
-
Thomas Glynn
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award.
